Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J3BY
|
||||
Former ID |
DIB007694
|
||||
Drug Name |
Pimagedine HCl
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetic kidney disease [ICD10:E11.22] | Phase 2/3 | [546189] | ||
Company |
Synvista Therapeutics
|
||||
Structure |
Download2D MOL |
||||
Formula |
CH7ClN4
|
||||
Canonical SMILES |
Cl.NNC(=N)N
|
||||
InChI |
1S/CH6N4.ClH/c2-1(3)5-4;/h4H2,(H4,2,3,5);1H
|
||||
InChIKey |
UBDZFAGVPPMTIT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Inhibitor | [529604] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.